Dalsegno Solutions Pty Ltd

Status: Registered
Australian Company Number: 601700065
Australian Business Number: 81601700065
Registration date: Mon, 8th Sep 2014
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Dalsegno Solutions Pty Ltd is a limited by shares Australian proprietary company. Located at QLD 4217 since 2023-07-19 the company is, as the updated on 2023-07-19 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2014-09-08. Known company numbers for Dalsegno Solutions Pty Ltd are as follows: ACN - 601700065, Australian Business Number - 81601700065. This Australian proprietary company was previously located in QLD 4164 (from 2021-03-05 to 2023-07-19), QLD 4069 (from 2014-09-08 to 2021-03-05).

Details for ABN 81601700065

Type: Australian Private Company

ABN Status

Status From To
Active Mon, 8th Sep 2014 current

Main Name

Name From To
Dalsegno Solutions Pty Ltd Mon, 8th Sep 2014 current

Main Location

Location From To
QLD 4217 Wed, 19th Jul 2023 current
QLD 4164 Fri, 5th Mar 2021 Wed, 19th Jul 2023
QLD 4069 Mon, 8th Sep 2014 Fri, 5th Mar 2021

Goods & Services Tax (GST)

Status From To
Registered Mon, 8th Sep 2014 current

Advertisements

Find company

QLD 4217 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.